Category: "Human Interest Epilepsy"

NeurologyLive® Year in Review 2023: Top Stories in Epilepsy and Seizure Disorders

NeurologyLive® Year in Review 2023: Top Stories in Epilepsy and Seizure Disorders

In 2023, the NeurologyLive® staff was a busy bunch, covering clinical news and data readouts from around the world across a number of key neurology subspecialty areas. From major study publications and FDA decisions to societal conference sessions and expert interviews, the team spent all year bringing the latest information to the website’s front page. Among our […]

This Antiseizure Medication Is Effective, Safe for Focal Seizures in Asian Patients

This Antiseizure Medication Is Effective, Safe for Focal Seizures in Asian Patients

Over a 12-week treatment period, adjunctive brivaracetam demonstrated efficacy and safety in Asian patients with focal seizure onset. Among Asian patients with focal onset seizures, brivaracetam, an antiseizure medication, successfully demonstrated efficacy and tolerability compared to placebo, according to study results presented at the American Epilepsy Society (AES) 2023 annual meeting, held from December 1 […]

ADHD Among Unexpected Issues With Seizure Meds in Children

ADHD Among Unexpected Issues With Seizure Meds in Children

ORLANDO, Fla.—New data from Nationwide Children’s Hospital suggest comorbidities and social factors, not the type of or dose of an anti-seizure medication (ASM), are the primary drivers of side effect intensity in young patients with epilepsy, according to a presentation at the 2023 annual meeting of the American Epilepsy Society. The researchers looked at the […]

Keto Diet on Par With Further Medication for Infants With Drug-Resistant Epilepsy

Keto Diet on Par With Further Medication for Infants With Drug-Resistant Epilepsy

— Diet may be considered a treatment option for some infants who continue to have seizures A ketogenic diet was similar in efficacy and tolerability to further anti-seizure medication for infants with drug-resistant epilepsy, a randomized clinical trial in the U.K. found. On the study’s primary outcome, the median number of seizures per day at […]

RECENT NEWS